Biopharmaceuticals

The value of partnership

Many of the world's leading research-oriented biopharmaceutical companies and top ranking pharmaceutical organisations have discovered the value of partnership with Boehringer Ingelheim. We have proved time and time again that we have the experience and the capability to convert promising product ideas into commercial reality on a global scale.

Latest Biopharmaceuticals Press Releases

26.01.2012	Boehringer Ingelheim launches ‘Lean-to-Clinic’ program for fast drug product supply
01.12.2011	Boehringer Ingelheim and AVEO Pharmaceuticals announce manufacturing agreement for ficlatuzumab
26.09.2011	Boehringer Ingelheim expands its Business with Biosimilars
07.09.2011	Boehringer Ingelheim wins Frost & Sullivan Award for Biopharmaceutical Contract Manufacturing
10.08.2011	Boehringer Ingelheim licenses ProBioGen's novel GlymaxX® technology
20.06.2011	Boehringer Ingelheim extends "one stop shop" service with new fill and finish capabilities
31.05.2011	Boehringer Ingelheim extends its manufacturing agreement for Betaferon ^® with Bayer HealthCare
25.03.2011	Boehringer Ingelheim finalizes acquisition of AMGEN’s Fremont facility in the USA
16.03.2011	MorphoSys Signs Manufacturing Agreement with Boehringer Ingelheim
15.02.2011	Pfēnex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the use of Pfēnex Expression Technology™
09.02.2011	Elan and Boehringer Ingelheim Announce Development and Manufacturing Agreement for Elan’s Antibody-Based Therapeutics Pipeline
18.01.2011	Boehringer Ingelheim to Purchase Amgen’s Fremont (USA) Facility
11.11.2010	Boehringer Ingelheim RCV and Fresenius Kabi successfully coupled HES to a therapeutic protein in an industrial scale applying Fresenius Kabi’s HESylation® Technology
11.11.2010	Collaboration of Boehringer Ingelheim and VTU Technology in Technology and Marketing benefits customers with broader services

Further press releases

Biopharmaceuticals

About us

Boehringer Ingelheim is one of the leading companies for development and manufacture of biopharmaceuticals.

read more
Development & Production

Working in partnership with Boehringer Ingelheim provides access to a state-of-the-art biopharmaceutical environment.

read more
Track Record

Boehringer Ingelheim has established its reputation with a successful market introduction of 15 DNA-derived biopharmaceutical products.

read more
Customer Services

As a partner in biopharmaceutical process science and manufacturing, Boehringer Ingelheim offers world-class expertise.

read more
Production Alliance Network

With the Production Alliance Network, Boehringer Ingelheim complements its worldwide strategic manufacturing capabilities.

read more
Information Material

You are welcome to download Boehringer Ingelheim Biopharmaceuticals information material for your personal use, subject to our terms of use.

read more
Upcoming Events

Corporate Division Biopharmaceuticals and the corresponding operation units are frequent exhibitors and participants in many of the world's leading biopharmaceutical events.

read more